In summary, the addition of AR, AB23A, and AF24A could help sensitize chemoresistant cancer cells to conventional anticancer drugs, thus eventually preventing chemotherapy failure or tumor recurrence induced by a decreased sensitivity of tumor cells. This evidence concerns the gene AR and neoplasm.